Jiazhou Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiazhou Yu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Shanquan Chen
School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong, China
6 shared publications - Dong Dong
JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
5 shared publications - Huanyu Zhang
Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China
5 shared publications Jean H. Kim
Department of Epidemiology and Biostatistics, Jockey Club School of Public Health and Primary Care, Chinese University of Hong Kong
2 shared publications- Jean Hee Kim
Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong
2 shared publications - Richard Huan Xu
Department of Rehabilitation Sciences, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Hong Kong SAR, China
2 shared publications
Latest Publications
- Open Access
- 15 July 2025
- Published by Springer Nature in BMC Medicine
- Vol. 23 (1) , 1-15
Discontinuity of social support among US adults with cognitive impairment before and after the confirmed diagnosis of dementia: a matched ambidirectional cohort study
Background: Despite increased attention on dementia, much remains unknown about the integration of clinical and non-clinical care, particularly regarding long-term social support, a primary source of non-clinical care. This study uniquely examines the effect of receiving a formal dementia diagnosis on the continuity of social support, an understudied transition point in dementia care pathways. Methods: In this ambidirectional cohort study, we examined ten waves of data from the Health and Retirement Survey(HRS) for US adults over 50 through 2000–2018. Eligibility was limited to participants with cognitive impairment. The exposure group were people with a confirmed dementia diagnosis (N = 1261), and the control group were matched by age, sex, race/ethnicity, and survey wave, but without a confirmed diagnosis (N = 12,604). Unmet social support was defined as reporting physical disability without receiving corresponding social support. Physical disability was assessed using measures of basic activities of daily living (BADLs) and instrumental activities of daily living (IADLs). The data were fitted using controlled interrupted time series analysis to explore the continuity of unmet social support before and after a diagnosis. Results: After dementia diagnosis, adults experienced a significant increase in unmet IADL support needs (coef = 0.10, 95% CI [0.07, 0.13]), particularly for making phone calls (coef = 0.74, 95% CI [0.16, 1.33]). By race/ethnicity, Hispanics showed a significant rise in unmet BADL support needs (coef = 0.74, 95% CI [0.03, 1.46]), especially for eating assistance (coef = 1.58, 95% CI [0.17, 2.99]). Blacks experienced increased unmet BADL needs in toileting (coef = 1.52, 95% CI [0.57, 2.47]) and IADL support (coef = 0.09, 95% CI [0.00, 0.17]). Sex disparities were also identified, with females showing decreased unmet BADL support(coef = − 0.55, 95% CI [− 1.03, − 0.06]) but increased unmet IADL support (coef = 0.08, 95% CI [0.04, 0.11]), while males experienced increased unmet toileting (coef = 0.78, 95% CI [0.03, 1.53]) and IADLs support (coef = 0.14, 95% CI [0.10, 0.18]). Conslusions: Our study identifies a disconnect in the care provided to individuals with dementia before and after their diagnosis. Notably, post-diagnosis, we observed substantial disparities in unmet social support needs across various racial groups. This highlights the need for more cohesive and equitable care strategies in the dementia care continuum.
- 15 July 2025
- Published by Springer Nature in BMC Medicine
- Vol. 23 (1) , 1-15
Open AccessDiscontinuity of social support among US adults with cognitive impairment before and after the confirmed diagnosis of dementia: a matched ambidirectional cohort study
Background: Despite increased attention on dementia, much remains unknown about the integration of clinical and non-clinical care, particularly regarding long-term social support, a primary source of non-clinical care. This study uniquely examines the effect of receiving a formal dementia diagnosis on the continuity of social support, an understudied transition point in dementia care pathways. Methods: In this ambidirectional cohort study, we examined ten waves of data from the Health and Retirement Survey(HRS) for US adults over 50 through 2000–2018. Eligibility was limited to participants with cognitive impairment. The exposure group were people with a confirmed dementia diagnosis (N = 1261), and the control group were matched by age, sex, race/ethnicity, and survey wave, but without a confirmed diagnosis (N = 12,604). Unmet social support was defined as reporting physical disability without receiving corresponding social support. Physical disability was assessed using measures of basic activities of daily living (BADLs) and instrumental activities of daily living (IADLs). The data were fitted using controlled interrupted time series analysis to explore the continuity of unmet social support before and after a diagnosis. Results: After dementia diagnosis, adults experienced a significant increase in unmet IADL support needs (coef = 0.10, 95% CI [0.07, 0.13]), particularly for making phone calls (coef = 0.74, 95% CI [0.16, 1.33]). By race/ethnicity, Hispanics showed a significant rise in unmet BADL support needs (coef = 0.74, 95% CI [0.03, 1.46]), especially for eating assistance (coef = 1.58, 95% CI [0.17, 2.99]). Blacks experienced increased unmet BADL needs in toileting (coef = 1.52, 95% CI [0.57, 2.47]) and IADL support (coef = 0.09, 95% CI [0.00, 0.17]). Sex disparities were also identified, with females showing decreased unmet BADL support(coef = − 0.55, 95% CI [− 1.03, − 0.06]) but increased unmet IADL support (coef = 0.08, 95% CI [0.04, 0.11]), while males experienced increased unmet toileting (coef = 0.78, 95% CI [0.03, 1.53]) and IADLs support (coef = 0.14, 95% CI [0.10, 0.18]). Conslusions: Our study identifies a disconnect in the care provided to individuals with dementia before and after their diagnosis. Notably, post-diagnosis, we observed substantial disparities in unmet social support needs across various racial groups. This highlights the need for more cohesive and equitable care strategies in the dementia care continuum.
- Open Access
- 15 April 2025
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 27 (S5) , 45-62
Real world evidence of insulin and biosimilar insulin therapy—Opportunities to improve adherence, outcomes and cost‐effectiveness
Insulin has been discovered for more than a century; however, its benefits to people with diabetes are yet to be fully realized due to barriers related to access, quality of care and costs. Insulin therapy remains the cornerstone of diabetes management. The multicausality of diabetes and its subtypes calls for comprehensive phenotyping and use of biomarkers to ensure timely use of insulin to achieve early glycaemic control for long‐term benefits. Biosimilar insulins are biologic products that closely resemble originator insulins without significant differences in safety or efficacy. The lower investment costs needed for research and development make biosimilar insulin more affordable to improve access. While the efficacy of insulin products is proven in controlled settings, real world evidence (RWE) from real world data (RWD) plays a crucial role in assessing the safety, efficacy, cost‐effectiveness, adherence to and impacts of different insulin products, including biosimilars, on clinical outcomes. In this narrative review, we summarized the trends of insulin use and patterns of biosimilar insulin utilization in real world practice across different regions. We reviewed RWE on clinical safety, efficacy and cost‐effectiveness of biosimilar insulin, as well as therapeutic inertia and non‐adherence with insulin therapy. We also highlighted barriers to insulin adherence and enablers for persistence, along with potential solutions to promote the use of insulin and technologies for optimizing glycaemic control in different subtypes of diabetes. During our extensive literature review, we identified data gaps in the usage of biosimilar insulin in real world practice. We advocate for implementing a diabetes register designed fit‐for‐purpose, managed by a trained doctor–nurse team with system support, to generate RWE. By setting up registers with structured data collection, we can generate high quality data for integrative analysis with electronic health records (EHR) and health claims to evaluate the impacts of insulin products and other diabetes programmes on clinical outcomes, quality of life and healthcare costs to inform practice and policies. Plain Language Summary: Diabetes affects approximately 10.5% of the global population and insulin is a vital treatment for diabetes management. Insulin was discovered more than a century ago, although its benefits to people with diabetes are yet to be fully realized due to barriers related to access, quality of care, and costs. Real‐world evidence from real‐world data plays a crucial role in assessing the safety, efficacy, cost‐effectiveness, adherence to, and impacts of different insulin products, including biosimilars, on clinical outcomes. In this publication, the authors provided a detailed review of the patterns of use and cost‐effectiveness of biosimilar insulin, and identified major data gaps. The authors explained the methodology, utility, and limitations of generating real‐world evidence based on real‐world data from sources such as registers, electronic health records and health claims for assessing treatment effectiveness and safety. The authors proposed the implementation of a purpose‐built diabetes register with structured data collection, managed by a trained doctor–nurse team with system support. These high‐quality data can be integrated with electronic health records and health claims for evaluation of interventions, including insulin on outcomes, quality of life, and costs to inform practice and policy. Based on these premises and available data, the authors summarized trends in insulin use including biosimilar insulin, and reviewed real‐world evidence on the safety, efficacy, and cost‐effectiveness of these products. They also identified barriers like therapeutic inertia and non‐adherence, discussed enablers for persistence, and proposed solutions to evaluate the impacts of insulin products and other diabetes programs on clinical outcomes, quality of life, and healthcare costs to inform practice and policies.
- 15 April 2025
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 27 (S5) , 45-62
Open AccessReal world evidence of insulin and biosimilar insulin therapy—Opportunities to improve adherence, outcomes and cost‐effectiveness
Insulin has been discovered for more than a century; however, its benefits to people with diabetes are yet to be fully realized due to barriers related to access, quality of care and costs. Insulin therapy remains the cornerstone of diabetes management. The multicausality of diabetes and its subtypes calls for comprehensive phenotyping and use of biomarkers to ensure timely use of insulin to achieve early glycaemic control for long‐term benefits. Biosimilar insulins are biologic products that closely resemble originator insulins without significant differences in safety or efficacy. The lower investment costs needed for research and development make biosimilar insulin more affordable to improve access. While the efficacy of insulin products is proven in controlled settings, real world evidence (RWE) from real world data (RWD) plays a crucial role in assessing the safety, efficacy, cost‐effectiveness, adherence to and impacts of different insulin products, including biosimilars, on clinical outcomes. In this narrative review, we summarized the trends of insulin use and patterns of biosimilar insulin utilization in real world practice across different regions. We reviewed RWE on clinical safety, efficacy and cost‐effectiveness of biosimilar insulin, as well as therapeutic inertia and non‐adherence with insulin therapy. We also highlighted barriers to insulin adherence and enablers for persistence, along with potential solutions to promote the use of insulin and technologies for optimizing glycaemic control in different subtypes of diabetes. During our extensive literature review, we identified data gaps in the usage of biosimilar insulin in real world practice. We advocate for implementing a diabetes register designed fit‐for‐purpose, managed by a trained doctor–nurse team with system support, to generate RWE. By setting up registers with structured data collection, we can generate high quality data for integrative analysis with electronic health records (EHR) and health claims to evaluate the impacts of insulin products and other diabetes programmes on clinical outcomes, quality of life and healthcare costs to inform practice and policies. Plain Language Summary: Diabetes affects approximately 10.5% of the global population and insulin is a vital treatment for diabetes management. Insulin was discovered more than a century ago, although its benefits to people with diabetes are yet to be fully realized due to barriers related to access, quality of care, and costs. Real‐world evidence from real‐world data plays a crucial role in assessing the safety, efficacy, cost‐effectiveness, adherence to, and impacts of different insulin products, including biosimilars, on clinical outcomes. In this publication, the authors provided a detailed review of the patterns of use and cost‐effectiveness of biosimilar insulin, and identified major data gaps. The authors explained the methodology, utility, and limitations of generating real‐world evidence based on real‐world data from sources such as registers, electronic health records and health claims for assessing treatment effectiveness and safety. The authors proposed the implementation of a purpose‐built diabetes register with structured data collection, managed by a trained doctor–nurse team with system support. These high‐quality data can be integrated with electronic health records and health claims for evaluation of interventions, including insulin on outcomes, quality of life, and costs to inform practice and policy. Based on these premises and available data, the authors summarized trends in insulin use including biosimilar insulin, and reviewed real‐world evidence on the safety, efficacy, and cost‐effectiveness of these products. They also identified barriers like therapeutic inertia and non‐adherence, discussed enablers for persistence, and proposed solutions to evaluate the impacts of insulin products and other diabetes programs on clinical outcomes, quality of life, and healthcare costs to inform practice and policies.
- Open Access
- 21 November 2024
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 52, 101247
Population attributable fractions for modifiable risk factors of dementia in China: an updated analysis
- 21 November 2024
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 52, 101247
Open AccessPopulation attributable fractions for modifiable risk factors of dementia in China: an updated analysis
- Top Cited PapersOpen Access
- 2 September 2024
- Published by Springer Nature in BMC Medicine
- Vol. 22 (1) , 1-11
Integrating machine learning and artificial intelligence in life-course epidemiology: pathways to innovative public health solutions
The integration of machine learning (ML) and artificial intelligence (AI) techniques in life-course epidemiology offers remarkable opportunities to advance our understanding of the complex interplay between biological, social, and environmental factors that shape health trajectories across the lifespan. This perspective summarizes the current applications, discusses future potential and challenges, and provides recommendations for harnessing ML and AI technologies to develop innovative public health solutions. ML and AI have been increasingly applied in epidemiological studies, demonstrating their ability to handle large, complex datasets, identify intricate patterns and associations, integrate multiple and multimodal data types, improve predictive accuracy, and enhance causal inference methods. In life-course epidemiology, these techniques can help identify sensitive periods and critical windows for intervention, model complex interactions between risk factors, predict individual and population-level disease risk trajectories, and strengthen causal inference in observational studies. By leveraging the five principles of life-course research proposed by Elder and Shanahan—lifespan development, agency, time and place, timing, and linked lives—we discuss a framework for applying ML and AI to uncover novel insights and inform targeted interventions. However, the successful integration of these technologies faces challenges related to data quality, model interpretability, bias, privacy, and equity. To fully realize the potential of ML and AI in life-course epidemiology, fostering interdisciplinary collaborations, developing standardized guidelines, advocating for their integration in public health decision-making, prioritizing fairness, and investing in training and capacity building are essential. By responsibly harnessing the power of ML and AI, we can take significant steps towards creating healthier and more equitable futures across the life course.
- 2 September 2024
- Published by Springer Nature in BMC Medicine
- Vol. 22 (1) , 1-11
Top Cited PapersOpen AccessIntegrating machine learning and artificial intelligence in life-course epidemiology: pathways to innovative public health solutions
The integration of machine learning (ML) and artificial intelligence (AI) techniques in life-course epidemiology offers remarkable opportunities to advance our understanding of the complex interplay between biological, social, and environmental factors that shape health trajectories across the lifespan. This perspective summarizes the current applications, discusses future potential and challenges, and provides recommendations for harnessing ML and AI technologies to develop innovative public health solutions. ML and AI have been increasingly applied in epidemiological studies, demonstrating their ability to handle large, complex datasets, identify intricate patterns and associations, integrate multiple and multimodal data types, improve predictive accuracy, and enhance causal inference methods. In life-course epidemiology, these techniques can help identify sensitive periods and critical windows for intervention, model complex interactions between risk factors, predict individual and population-level disease risk trajectories, and strengthen causal inference in observational studies. By leveraging the five principles of life-course research proposed by Elder and Shanahan—lifespan development, agency, time and place, timing, and linked lives—we discuss a framework for applying ML and AI to uncover novel insights and inform targeted interventions. However, the successful integration of these technologies faces challenges related to data quality, model interpretability, bias, privacy, and equity. To fully realize the potential of ML and AI in life-course epidemiology, fostering interdisciplinary collaborations, developing standardized guidelines, advocating for their integration in public health decision-making, prioritizing fairness, and investing in training and capacity building are essential. By responsibly harnessing the power of ML and AI, we can take significant steps towards creating healthier and more equitable futures across the life course.
- 29 August 2024
- Published by American Psychological Association (APA) in Cultural Diversity & Ethnic Minority Psychology
Perceived discrimination and mental health among female migrant domestic workers in Hong Kong: A sequential explanatory mixed-methods study.
Female migrant domestic workers (MDW), often unemployed in their home country, are household workers that migrate abroad for better wages. Although poor employment conditions have shown detrimental effects on MDWs health, the mental health effect of perceived discrimination remains understudied among MDWs. This mixed-methods study seeks to (a) assess the association between perceived discrimination and mental health among female MDWs and (b) explore in-depth the common ways MDWs experience discrimination. A cross-sectional self-administered survey (n = 1965) was conducted among Filipino and Indonesian MDWs from August 2020 to August 2021 in Hong Kong. A multivariable logistic regression model, controlling for background characteristics, assessed associations between perceived discrimination with anxiety and depression. Qualitative semistructured interviews were then conducted (n = 20) to provide in-depth information about perceived discrimination. Thematic analysis was used to identify the contexts and types of discrimination experienced. Among survey respondents, 60.4% reported ever experiencing discrimination, and 10.5% reported often/always feeling discriminated against. Of MDWs, 18.1% and 31.5% were classified with anxiety and depression, respectively. MDWs reporting higher frequency of discrimination were at increased risk of anxiety (ORadj: 2.30-6.60) and depression (ORadj: 2.06-5.91). In-depth interviews revealed that perceived discrimination inside the workplace (from overwork, lack of autonomy, and employer-imposed restrictions) and outside the workplace (from MDW policies) had strong effects on MDWs' mental health. Increased availability to mental health services should be considered. To improve MDW mental health, policymakers may also regulate maximum weekly working hours and ensure minimum standards for living environments. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
- 29 August 2024
- Published by American Psychological Association (APA) in Cultural Diversity & Ethnic Minority Psychology
Perceived discrimination and mental health among female migrant domestic workers in Hong Kong: A sequential explanatory mixed-methods study.
Female migrant domestic workers (MDW), often unemployed in their home country, are household workers that migrate abroad for better wages. Although poor employment conditions have shown detrimental effects on MDWs health, the mental health effect of perceived discrimination remains understudied among MDWs. This mixed-methods study seeks to (a) assess the association between perceived discrimination and mental health among female MDWs and (b) explore in-depth the common ways MDWs experience discrimination. A cross-sectional self-administered survey (n = 1965) was conducted among Filipino and Indonesian MDWs from August 2020 to August 2021 in Hong Kong. A multivariable logistic regression model, controlling for background characteristics, assessed associations between perceived discrimination with anxiety and depression. Qualitative semistructured interviews were then conducted (n = 20) to provide in-depth information about perceived discrimination. Thematic analysis was used to identify the contexts and types of discrimination experienced. Among survey respondents, 60.4% reported ever experiencing discrimination, and 10.5% reported often/always feeling discriminated against. Of MDWs, 18.1% and 31.5% were classified with anxiety and depression, respectively. MDWs reporting higher frequency of discrimination were at increased risk of anxiety (ORadj: 2.30-6.60) and depression (ORadj: 2.06-5.91). In-depth interviews revealed that perceived discrimination inside the workplace (from overwork, lack of autonomy, and employer-imposed restrictions) and outside the workplace (from MDW policies) had strong effects on MDWs' mental health. Increased availability to mental health services should be considered. To improve MDW mental health, policymakers may also regulate maximum weekly working hours and ensure minimum standards for living environments. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
- Open Access
- 27 August 2024
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 10 (1) , e57353
Patterns of the Health and Economic Burden of 33 Rare Diseases in China: Nationwide Web-Based Study
Background: Rare diseases (RDs) affect millions of individuals collectively worldwide, contributing to significant burdens on patients and families in various aspects. However, there is a lack of evidence on the underlying patterns of burdens among diverse RDs for informing targeted social and health policies to address the unmet needs of this vulnerable population. Objective: This study aimed to examine the underlying patterns of the health and economic burden of 33 different RDs in China and identify the potential determinants. Methods: A nationwide internet-based cross-sectional survey was conducted in China between 2019 and 2020. Physical and mental health burden was measured by health-related quality of life. Economic burden was evaluated based on the proportions of direct medical, direct nonmedical, and indirect costs relative to household income. We used cluster analysis to identify patterns of health and economic burdens and conducted multinomial logistic regression to explore potential predictors of cluster membership. Results: The study included 8454 adults and 8491 children affected by 33 RDs. The following 3 clusters were identified: “extremely high burden” (representing 92/8454, 1.1% and 19/8491, 0.2% of adult and pediatric patients, respectively), “overall high burden” (5933/8454, 70.2% and 4864/8491, 57.3%, respectively), and “overall low burden” (2429/8454, 28.7% and 3608/8491, 42.5%, respectively). Wilson disease, Marfan syndrome, and Langerhans cell histiocytosis more likely resulted in an “extremely high burden” than others. Poverty was significantly associated with being in this extremely high burden group. Diseases causing neuromuscular symptoms and requiring long-term treatment (eg, amyotrophic lateral sclerosis, spinocerebellar ataxia, and Dravet syndrome) were prevalent in the “overall high burden” group. Key predictors of this group included older age, lower socioeconomic status, diagnostic delay, and comorbidity. Conclusions: This study provides novel and valuable evidence on the burden of RDs in developing regions like China. The findings reveal significant disparities in the impact of RDs, emphasizing the need for targeted health care interventions and policies.
- 27 August 2024
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 10 (1) , e57353
Open AccessPatterns of the Health and Economic Burden of 33 Rare Diseases in China: Nationwide Web-Based Study
Background: Rare diseases (RDs) affect millions of individuals collectively worldwide, contributing to significant burdens on patients and families in various aspects. However, there is a lack of evidence on the underlying patterns of burdens among diverse RDs for informing targeted social and health policies to address the unmet needs of this vulnerable population. Objective: This study aimed to examine the underlying patterns of the health and economic burden of 33 different RDs in China and identify the potential determinants. Methods: A nationwide internet-based cross-sectional survey was conducted in China between 2019 and 2020. Physical and mental health burden was measured by health-related quality of life. Economic burden was evaluated based on the proportions of direct medical, direct nonmedical, and indirect costs relative to household income. We used cluster analysis to identify patterns of health and economic burdens and conducted multinomial logistic regression to explore potential predictors of cluster membership. Results: The study included 8454 adults and 8491 children affected by 33 RDs. The following 3 clusters were identified: “extremely high burden” (representing 92/8454, 1.1% and 19/8491, 0.2% of adult and pediatric patients, respectively), “overall high burden” (5933/8454, 70.2% and 4864/8491, 57.3%, respectively), and “overall low burden” (2429/8454, 28.7% and 3608/8491, 42.5%, respectively). Wilson disease, Marfan syndrome, and Langerhans cell histiocytosis more likely resulted in an “extremely high burden” than others. Poverty was significantly associated with being in this extremely high burden group. Diseases causing neuromuscular symptoms and requiring long-term treatment (eg, amyotrophic lateral sclerosis, spinocerebellar ataxia, and Dravet syndrome) were prevalent in the “overall high burden” group. Key predictors of this group included older age, lower socioeconomic status, diagnostic delay, and comorbidity. Conclusions: This study provides novel and valuable evidence on the burden of RDs in developing regions like China. The findings reveal significant disparities in the impact of RDs, emphasizing the need for targeted health care interventions and policies.
- Open Access
- 1 July 2024
- Published by Wiley in Drug and Alcohol Review
- Vol. 43 (6) , 1435-1444
Who is being targeted by alcohol social media marketing? A study of Chinese young adults in Hong Kong
Introduction: Due to the widespread use of social media by young adults, the alcohol industry has been increasingly using social media marketing (SMM) to target potential customers. This study examines the prevalence and factors associated with past‐month exposure to alcohol SMM among young Chinese adults, a group with rapidly increasing uptake of alcohol consumption.Methods: An anonymous, random telephone survey was conducted between June and August 2021 on Hong Kong Chinese residents between 18 and 34 years old (n = 675).Results: Of respondents, 52.3% reported past‐month exposure to alcohol SMM (68.6% of past‐month drinkers and 48.0% of non‐past‐month drinkers, p < 0.05) while 71.6% reported exposure to non‐SMM alcohol marketing. Direct alcohol SMM exposure was reported by 40.9% (e.g., business‐to‐consumer postings, alcohol banner ads) while 27.4% of respondents reported exposure to indirect alcohol SMM marketing (e.g., shared/‘liked’ alcohol brand posts). Of those exposed to alcohol SMM, 13.7–15.5% reported that the various forms indirect alcohol SMM influenced them to drink more (vs. 6.2–8.9% for direct alcohol SMM). Being male, lower‐income, university educated and spirits/cocktail drinker were independently associated with exposure to direct alcohol SMM (ORmv 1.71–3.14). Past‐month exposure to indirect alcohol SMM was independently associated with lower income, not working full‐time and drinking any type of alcohol (ORmv 1.59–4.44).Discussion and Conclusion: The comparative effectiveness of indirect SMM on influencing young adults drinking intentions may be a form of peer endorsement of drinking. The pervasiveness of alcohol SMM and lack of alcohol SMM policies may indicate the need for greater alcohol marketing regulation in this region.
- 1 July 2024
- Published by Wiley in Drug and Alcohol Review
- Vol. 43 (6) , 1435-1444
Open AccessWho is being targeted by alcohol social media marketing? A study of Chinese young adults in Hong Kong
Introduction: Due to the widespread use of social media by young adults, the alcohol industry has been increasingly using social media marketing (SMM) to target potential customers. This study examines the prevalence and factors associated with past‐month exposure to alcohol SMM among young Chinese adults, a group with rapidly increasing uptake of alcohol consumption.Methods: An anonymous, random telephone survey was conducted between June and August 2021 on Hong Kong Chinese residents between 18 and 34 years old (n = 675).Results: Of respondents, 52.3% reported past‐month exposure to alcohol SMM (68.6% of past‐month drinkers and 48.0% of non‐past‐month drinkers, p < 0.05) while 71.6% reported exposure to non‐SMM alcohol marketing. Direct alcohol SMM exposure was reported by 40.9% (e.g., business‐to‐consumer postings, alcohol banner ads) while 27.4% of respondents reported exposure to indirect alcohol SMM marketing (e.g., shared/‘liked’ alcohol brand posts). Of those exposed to alcohol SMM, 13.7–15.5% reported that the various forms indirect alcohol SMM influenced them to drink more (vs. 6.2–8.9% for direct alcohol SMM). Being male, lower‐income, university educated and spirits/cocktail drinker were independently associated with exposure to direct alcohol SMM (ORmv 1.71–3.14). Past‐month exposure to indirect alcohol SMM was independently associated with lower income, not working full‐time and drinking any type of alcohol (ORmv 1.59–4.44).Discussion and Conclusion: The comparative effectiveness of indirect SMM on influencing young adults drinking intentions may be a form of peer endorsement of drinking. The pervasiveness of alcohol SMM and lack of alcohol SMM policies may indicate the need for greater alcohol marketing regulation in this region.
- Open Access
- 13 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Patterns of the Health and Economic Burden of 33 Rare Diseases in China: Nationwide Web-Based Study (Preprint)
BACKGROUND Rare diseases (RDs) affect millions of individuals collectively worldwide, contributing to significant burdens on patients and families in various aspects. However, there is a lack of evidence on the underlying patterns of burdens among diverse RDs for informing targeted social and health policies to address the unmet needs of this vulnerable population. OBJECTIVE This study aimed to examine the underlying patterns of the health and economic burden of 33 different RDs in China and identify the potential determinants. METHODS A nationwide internet-based cross-sectional survey was conducted in China between 2019 and 2020. Physical and mental health burden was measured by health-related quality of life. Economic burden was evaluated based on the proportions of direct medical, direct nonmedical, and indirect costs relative to household income. We used cluster analysis to identify patterns of health and economic burdens and conducted multinomial logistic regression to explore potential predictors of cluster membership. RESULTS The study included 8454 adults and 8491 children affected by 33 RDs. The following 3 clusters were identified: “extremely high burden” (representing 92/8454, 1.1% and 19/8491, 0.2% of adult and pediatric patients, respectively), “overall high burden” (5933/8454, 70.2% and 4864/8491, 57.3%, respectively), and “overall low burden” (2429/8454, 28.7% and 3608/8491, 42.5%, respectively). Wilson disease, Marfan syndrome, and Langerhans cell histiocytosis more likely resulted in an “extremely high burden” than others. Poverty was significantly associated with being in this extremely high burden group. Diseases causing neuromuscular symptoms and requiring long-term treatment (eg, amyotrophic lateral sclerosis, spinocerebellar ataxia, and Dravet syndrome) were prevalent in the “overall high burden” group. Key predictors of this group included older age, lower socioeconomic status, diagnostic delay, and comorbidity. CONCLUSIONS This study provides novel and valuable evidence on the burden of RDs in developing regions like China. The findings reveal significant disparities in the impact of RDs, emphasizing the need for targeted health care interventions and policies.
- 13 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPatterns of the Health and Economic Burden of 33 Rare Diseases in China: Nationwide Web-Based Study (Preprint)
BACKGROUND Rare diseases (RDs) affect millions of individuals collectively worldwide, contributing to significant burdens on patients and families in various aspects. However, there is a lack of evidence on the underlying patterns of burdens among diverse RDs for informing targeted social and health policies to address the unmet needs of this vulnerable population. OBJECTIVE This study aimed to examine the underlying patterns of the health and economic burden of 33 different RDs in China and identify the potential determinants. METHODS A nationwide internet-based cross-sectional survey was conducted in China between 2019 and 2020. Physical and mental health burden was measured by health-related quality of life. Economic burden was evaluated based on the proportions of direct medical, direct nonmedical, and indirect costs relative to household income. We used cluster analysis to identify patterns of health and economic burdens and conducted multinomial logistic regression to explore potential predictors of cluster membership. RESULTS The study included 8454 adults and 8491 children affected by 33 RDs. The following 3 clusters were identified: “extremely high burden” (representing 92/8454, 1.1% and 19/8491, 0.2% of adult and pediatric patients, respectively), “overall high burden” (5933/8454, 70.2% and 4864/8491, 57.3%, respectively), and “overall low burden” (2429/8454, 28.7% and 3608/8491, 42.5%, respectively). Wilson disease, Marfan syndrome, and Langerhans cell histiocytosis more likely resulted in an “extremely high burden” than others. Poverty was significantly associated with being in this extremely high burden group. Diseases causing neuromuscular symptoms and requiring long-term treatment (eg, amyotrophic lateral sclerosis, spinocerebellar ataxia, and Dravet syndrome) were prevalent in the “overall high burden” group. Key predictors of this group included older age, lower socioeconomic status, diagnostic delay, and comorbidity. CONCLUSIONS This study provides novel and valuable evidence on the burden of RDs in developing regions like China. The findings reveal significant disparities in the impact of RDs, emphasizing the need for targeted health care interventions and policies.
- Open Access
- 27 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Change in quality of life in adults with late-onset Pompe disease receiving under-dose of enzyme replacement therapy in a nationwide registry: a retrospective matched cohort study from China
Background and Objective: Pompe disease is a rare inherited neuromuscular disorder. Due to the high cost of enzyme replacement therapy (ERT), most of adults with late-onset Pompe disease (LOPD) who received ERT used the medication with insufficient doses in China. This study aimed to compare the...
- 27 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Open AccessChange in quality of life in adults with late-onset Pompe disease receiving under-dose of enzyme replacement therapy in a nationwide registry: a retrospective matched cohort study from China
Background and Objective: Pompe disease is a rare inherited neuromuscular disorder. Due to the high cost of enzyme replacement therapy (ERT), most of adults with late-onset Pompe disease (LOPD) who received ERT used the medication with insufficient doses in China. This study aimed to compare the...
- Open Access
- 27 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Social support and medication compliance among myasthenia gravis patients in China: mediating role of mental health and self-efficacy
Background and Objectives: Myasthenia gravis (MG), a rare chronic neuromuscular disorder, is characterized by progressive physical decline and requires long-term pharmacological treatment. Due to the decline of physical and social abilities, MG patients are in great need of social support,...
- 27 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Open AccessSocial support and medication compliance among myasthenia gravis patients in China: mediating role of mental health and self-efficacy
Background and Objectives: Myasthenia gravis (MG), a rare chronic neuromuscular disorder, is characterized by progressive physical decline and requires long-term pharmacological treatment. Due to the decline of physical and social abilities, MG patients are in great need of social support,...